EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Intellipharmaceutics International Inc. (IPCIQ) had EBITDA Margin of -4023.32% for the most recently reported fiscal year, ending 2022-11-30.
| Income Statement Financials | |
$0.07M |
|
$-2.89M |
|
-- |
|
$0.07M |
|
$2.92M |
|
$-2.85M |
|
$-0.04M |
|
$-2.89M |
|
$-2.93M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.94M |
|
$-2.85M |
|
$-2.64M |
|
33.09M |
|
33.09M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$0.49M |
|
$0.79M |
|
$0.94M |
|
$1.43M |
|
$12.01M |
|
-- |
|
-- |
|
$12.01M |
|
$-10.58M |
|
$-10.58M |
|
$-10.58M |
|
33.09M |
|
| Cash Flow Statement Financials | |
$-1.39M |
|
$0.50M |
|
$0.20M |
|
$0.77M |
|
$0.08M |
|
$-0.69M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-- |
|
-0.20 |
|
100.00% |
|
-4336.82% |
|
-4336.82% |
|
|
EBITDA Margin |
-4023.32% |
-4392.43% |
|
-4400.55% |
|
$-0.89M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
27.35% |
|
27.35% |
|
-201.98% |
|
27.35% |
|
$-0.32 |
|
$-0.03 |
|
$-0.04 |
|